GSK and Pfizer to Face 75,000 Zantac Cancer Lawsuits in Delaware, Shares Plunge 10%

Jun 3, 2024, 07:23 AM

GSK and Pfizer are set to face approximately 75,000 lawsuits in Delaware state court over claims that their former heartburn treatment, Zantac, causes cancer. A judge ruled that the evidence supporting these claims can be heard by juries, dismissing GSK's motions to exclude plaintiffs' witnesses. Following the ruling, GSK shares plunged by up to 10%, reflecting investor concerns over the potential impact of the lawsuits on the company.